连获两轮融资！MetaNovas AI创新原料加速落地全球美妆品牌

Core Viewpoint - The article emphasizes that MetaNovas is leading the transformation of molecular research and development through its proprietary Ag e n ti c AI system, which has garnered significant investment and recognition in the beauty and health industries [3][30][34]. Financing and Market Recognition - MetaNovas has successfully completed two rounds of financing (A+ and A++) led by top industry players and financial institutions focused on AI and deep technology, indicating strong market confidence in its technological and commercial capabilities [3][4][30]. - The company has received investments from notable firms such as Kangaroo Mom Group and OEM Yayan Group, as well as venture capital firms like Hillhouse Capital and Fuhua Capital [4][30]. Technological Advancements - Since its establishment in 2021, MetaNovas has focused on integrating AI with life sciences to enhance the consumer health industry, particularly in beauty, personal care, and medical devices [4][5]. - The company has developed a unique Ag e n ti c AI autonomous research and development system, which allows for a comprehensive approach to molecular design, from target prediction to regulatory compliance and industrial application [5][8]. Industry Challenges and Solutions - The beauty raw materials industry faces challenges such as long R&D cycles, high trial-and-error costs, and low success rates, with traditional methods taking 3-5 years and having a success rate of less than 10% [8]. - MetaNovas addresses these issues by utilizing generative AI and multi-omics analysis to streamline the discovery and design of new materials, providing a full-cycle solution from molecular design to mass production [5][8]. Product Development and Market Application - The company has successfully commercialized several AI-designed peptides and is expanding its product line to include innovative small molecules and RNA products [9][14]. - MetaNovas has achieved significant milestones, including the first AI-designed new molecular raw material to receive INCI certification and the first AI-designed peptide to complete medical device documentation [14][15]. Team and Infrastructure - MetaNovas boasts a highly qualified team, with 98% of its members holding master's degrees or higher, and a strong leadership team with backgrounds in AI, biology, pharmaceuticals, and beauty raw material development [10][11]. - The company has established a comprehensive R&D and production network across the US, China, and Europe, including AI supercomputing centers and efficacy testing facilities [11][12]. Global Expansion and Collaboration - MetaNovas is actively expanding its global presence and collaborating with leading beauty brands and research institutions to create a robust ecosystem for technology development, result transformation, and market application [19][29]. - The company has formed partnerships with major international brands like Unilever and Procter & Gamble, providing customized AI-designed raw materials for high-end product lines [27][29]. Future Outlook - The global beauty industry is shifting from a "traffic-driven" model to a "product-driven" one, with increasing consumer demand for innovative and effective ingredients [33]. - MetaNovas aims to continue enhancing its Ag e n ti c AI system and developing innovative raw materials that meet market demands, positioning itself as a leader in the beauty raw materials sector [31][34].